Lymphoma, T-Cell, Peripheral
2 competing products in clinical development for Lymphoma, T-Cell, Peripheral.
Pipeline by Phase
Pre-clinical1
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Denileukin diftitox + Cyclophosphamide + Doxorubicin + Vincristine + Prednisone | Eisai | Phase 2 | Completed | 35 |
| Remitoro | Eisai | Pre-clinical | Completed | 26 |